
BioAI Health
Manchester, NH, United States · bioaihealth.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
BioAI Health develops AI-powered biomarker tools and digital pathology services for pharma, research, and laboratory partners in precision oncology. It offers H&E-based biomarker model development, validation, biospecimen and data sourcing, and research-use-only products such as PredictLung. The company is based in Manchester, New Hampshire.
Their website has a general contact form; we send your quote request through it.
What they offer
AI Biomarker Development
Develops custom H&E-based AI biomarker models for predicting genetic mutations, protein expression, and therapy response in cancer research programs.
PredictLung
Provides a research-use-only digital pathology tool that generates biomarker-related probability outputs for lung cancer from H&E images.
Biospecimen Sourcing & Data Sourcing Services
Sources de-identified biospecimens and digital pathology data through partner biobanks and laboratories.
Predictive AI Models from H&E
Builds AI models to predict known genetic mutations and proteomic marker expression across multiple cancer types.
Novel Predictive AI Biomarkers
Develops AI models to predict treatment outcomes, disease resistance factors, adverse events, and long-term patient responses.
Quantitative Continuous Scoring
Provides AI-based continuous scoring from H&E images to generate more granular biomarker-related data than categorical IHC scores.
PredictX Platform
Uses multimodal AI, including causal modeling and in-silico phenotype projection, to support biomarker discovery and drug target identification.
What they work on
- Modalities
- Cell therapy
- Species and models
- NSCLC, SCLC, lung cancer, renal cancer, colorectal cancer, breast cancer, melanoma, prostate cancer, FFPE, H&E-stained tissue images, plasma, peripheral blood, and 2 more
- Assays and studies
- digital pathology, biomarker prediction, quantitative continuous scoring, model validation, external validation, causal modeling, in-silico phenotype projection, whole exome sequencing, NGS targeted panel, H&E image analysis, IHC analysis, molecular characterization
- Scale and capacity
- 80+ FFPE tissue blocks
- Therapeutic areas
- precision oncology, lung cancer, NSCLC, cancer biomarker research
- Turnaround
- hours
- What to send
- de-identified data · solid tumor blocks · plasma · peripheral blood · whole blood · urine · remnant FFPE tissue · H&E-stained digital images · IHC-stained digital pathology images
- Sites
- Manchester, United States
- Quality
- ISO/IEC 27001 (information security program) · IRB-approved protocols (biospecimen and data sourcing) · informed consent (biospecimen and data sourcing) · data-use agreements (de-identified partner data)
- Serves
- US, Europe, Asia
- Address
- 1662 Elm Street Manchester, NH 03101
Similar labs. 1st BASE, AbTherx, Aptamer Group, Avance Biosciences
Found in a contract services directory. Listing built from bioaihealth.com. Work here? Claim this listing.